Uric acid levels and risk of cognitive impairment: Dose-response meta-analysis of prospective cohort studies

Abstract

Purpose Studying the effects of uric acid levels on cognitive function and quantifying the dose-response relationship. Methods Based on PubMed and Embase search terms, we identified prospective cohort studies that included blood uric acid as a risk factor and cognitive impairment as a result up to September 2022. We extracted pooled relative risks (RRs) and corresponding 95% confidence intervals (CIs). Results Nine reports (including 488,915 participants and 5516 cognitive impairment cases) with median follow-up of 8.8–22 years were eligible for analyses. Compared with lowest category of blood uric acid concentration, the combined RR of cognitive impairment events in the highest classification was 0.81 (95% CI: 0.70–0.92, P < 0.001). Dose-response analysis of eight reports (including 484,297 participants and 5059 cognitive impairment cases) showed that there was no evidence of a curvilinear relationship between blood uric acid levels and cognitive impairment (P = 0.51 for nonlinear relationship). The summary RR of cognitive impairment for an increase of 1 mg/dL blood uric acid level was 0.98 (95% CI: 0.95–1.00; linear trend P = 0.07, I2 = 67.1%, heterogeneity P < 0.05). There was also a linear negative association between blood uric acid levels and cognitive impairment risk in the male subgroup analysis (RR = 0.97, 95% CI: 0.95–0.99, P < 0.05). Conclusion Levels of blood uric acid are not related to risk of cognitive impairment. A subgroup analysis shows that the rise in blood uric acid levels in the male population is related to a decreased risk of cognitive impairment. These results need to be confirmed by further studies.

Association between the serum uric acid/serum creatinine ratio and cognitive function in older adults: NHANES in the United States

“…However, whether UA is a protective or risk factor for cognitive function remains controversial. A meta-analysis in 2023 demonstrated no significant association between SUA levels and the risk of cognitive impairment 28 . In contrast, some studies support the protective role of SUA against cognitive impairment.…”

Progression of cognitive impairment in Parkinson’s disease correlates with uric acid concentration

“…High UA levels correlate negatively with cognitive function in the older adults (14). Studies also indicate that blood UA levels are not associated with the risk of cognitive impairment (15). Recently, correlations among UA, PD, and cognitive impairment have attracted attention.…”

Uric acid, cognitive disorders, neurodegeneration

“…Но если в целом уровень МК оказался не связан со снижением когнитивных нарушений, то у мужчин такая связь, хоть и слабая, но прослеживалась (для повышения уровня МК в крови на 1 мг/дл ОР 0,97, 95% ДИ 0,95-0,99; p<0,05). Для подтверждения этих результатов, по мнению авторов, необходимы больший размер выборки, более длительное время наблюдения и динамическое наблюдение за уровнем МК в крови [15]. Заслуживают внимания результаты исследования CADS (Chongqing Ageing & Dementia Study), в которое включены участники с различными степенями когнитивных нарушений, от их отсутствия до тяжелой деменции.…”